Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China

Novartis Pharmaceuticals · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
chinanis
retinopathy of prematurity, rop, nis, china, ranibizumab, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 905555
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.